19F Thoracic Radiotherapy for Lung Cancer

• Status: Completed
• Trial end date: 2019-06-25
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to determine the feasibility and efficiency of incorporating 19F MR functional lung imaging into the routine assessment of lung cancer patients prior to thoracic radiotherapy.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hal C Charles

Criteria

Inclusion Criteria:

• Subject has histologic or cytologic confirmation of lung cancer (NSCLC or Small cell) and has been recommended thoracic radiotherapy as part of standard of care management.

• Ability to undergo MR imaging, tolerate breath hold procedures and follow direction during the imaging process

• Karnofsky performance status ≥60, with expected survival of ≥6 months

• At least 18 years of age

• Patient is not pregnant

• Patient can be reliably reached for post-MRI follow up AE check.

• Patient able to sign a study specific informed consent form.

Exclusion Criteria:

• Any condition including, metallic implants or cardiac pacemakers that makes the candidate ineligible for MR imaging. (MRI research screening form will be completed prior to each MRI scan).

• Malignant pleural effusion or pericardial effusion